Anteris’ DurAVR THV Demonstrates 1% Heart Failure Hospitalization, Single-Digit Gradients and No Valve-Related Deaths at 1 Year in Patients with Small Aortic Annuli
Late-breaking 1-year data in 100 patients presented at PCR London Valves 2026: No moderate or severe paravalvular leak, 96% in NYHA class I/II and 97% free from moderate or severe prosthesis-patient mismatch at 30 days MINNEAPOLIS and BRISBANE, Nov.
